Boeri E - Search Results

1

Redistribution of human immunodeficiency virus type 1 variants resistant to protease inhibitors after a protease inhibitor-sparing regimen.

Gianotti N, Seminari E, Lazzarin A, Boeri E, Clementi M, Danise A, Salpietro S, Fusetti G, Castagna A. Gianotti N, et al. Among authors: boeri e. AIDS Res Hum Retroviruses. 2005 Jun;21(6):545-54. doi: 10.1089/aid.2005.21.545. AIDS Res Hum Retroviruses. 2005. PMID: 15989459 Clinical Trial.

2

Evolutionary characteristics of HIV type 1 variants resistant to protease inhibitors in the absence of drug-selective pressure.

Boeri E, Gianotti N, Canducci F, Hasson H, Giudici B, Castagna A, Lazzarin A, Clementi M. Boeri E, et al. AIDS Res Hum Retroviruses. 2003 Dec;19(12):1151-3. doi: 10.1089/088922203771881257. AIDS Res Hum Retroviruses. 2003. PMID: 14714567

3

Resistance to amprenavir before and after treatment with lopinavir/ritonavir in highly protease inhibitor-experienced HIV patients.

Hasson H, Gianotti N, Danise A, Seminari E, Boeri E, Nozza S, Castagna A, Lazzarin A. Hasson H, et al. Among authors: boeri e. AIDS. 2004 Jan 2;18(1):123-7. doi: 10.1097/00002030-200401020-00016. AIDS. 2004. PMID: 15090838

4

The NIQ of lopinavir is predictive of a 48-week virological response in highly treatment-experienced HIV-1-infected subjects treated with a lopinavir/ritonavir-containing regimen.

Castagna A, Gianotti N, Galli L, Danise A, Hasson H, Boeri E, Hoetelmans R, Nauwelaers D, Lazzarin A. Castagna A, et al. Among authors: boeri e. Antivir Ther. 2004 Aug;9(4):537-43. Antivir Ther. 2004. PMID: 15456085 Clinical Trial.

5

Impact of a treatment including tenofovir plus didanosine on the selection of the 65R mutation in highly drug-experienced HIV-infected patients.

Gianotti N, Seminari E, Fusetti G, Salpietro S, Boeri E, Galli A, Lazzarin A, Clementi M, Castagna A. Gianotti N, et al. Among authors: boeri e. AIDS. 2004 Nov 5;18(16):2205-8. doi: 10.1097/00002030-200411050-00016. AIDS. 2004. PMID: 15577657

6

Evaluation of atazanavir Ctrough, atazanavir genotypic inhibitory quotient, and baseline HIV genotype as predictors of a 24-week virological response in highly drug-experienced, HIV-infected patients treated with unboosted atazanavir.

Gianotti N, Seminari E, Guffanti M, Boeri E, Villani P, Regazzi M, Bigoloni A, Schira G, Tiberi S, Fusetti G, Lazzarin A, Castagna A. Gianotti N, et al. Among authors: boeri e. New Microbiol. 2005 Apr;28(2):119-25. New Microbiol. 2005. PMID: 16035256 Clinical Trial.

7

In vivo dynamics of the K103N mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in Human Immunodeficiency Virus-infected patients.

Gianotti N, Galli L, Boeri E, Maillard M, Serra G, Ratti D, Gallotta G, Vacchini D, Tremolada Y, Lazzarin A, Clementi M, Castagna A. Gianotti N, et al. Among authors: boeri e. New Microbiol. 2005 Oct;28(4):319-26. New Microbiol. 2005. PMID: 16386016

8

Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study).

Castagna A, Danise A, Menzo S, Galli L, Gianotti N, Carini E, Boeri E, Galli A, Cernuschi M, Hasson H, Clementi M, Lazzarin A. Castagna A, et al. Among authors: boeri e. AIDS. 2006 Apr 4;20(6):795-803. doi: 10.1097/01.aids.0000218542.08845.b2. AIDS. 2006. PMID: 16549962 Clinical Trial.

9

The 118I reverse transcriptase mutation is the only independent genotypic predictor of virologic failure to a stavudine-containing salvage therapy in HIV-1-infected patients.

Gianotti N, Galli L, Boeri E, De Bona A, Guffanti M, Danise A, Salpietro S, Lazzarin A, Castagna A. Gianotti N, et al. Among authors: boeri e. J Acquir Immune Defic Syndr. 2006 Apr 1;41(4):447-52. doi: 10.1097/01.qai.0000209903.89878.80. J Acquir Immune Defic Syndr. 2006. PMID: 16652052

10

Ability of different lopinavir genotypic inhibitory quotients to predict 48-week virological response in highly treatment-experienced HIV-infected patients receiving lopinavir/ritonavir.

Gianotti N, Galli L, Danise A, Hasson H, Boeri E, Lazzarin A, Castagna A. Gianotti N, et al. Among authors: boeri e. J Med Virol. 2006 Dec;78(12):1537-41. doi: 10.1002/jmv.20736. J Med Virol. 2006. PMID: 17063520

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Search Page

Filters